Aicardi–Goutières syndrome clinical trials at UCSF

1 research study open to eligible people

Aicardi-Goutières syndrome is a rare disorder that affects the brain and immune system. At UCSF, research trials focus on collecting data and samples from leukodystrophy patients. These studies are important for understanding the syndrome and broader myelin issues.

Showing trials for

  • Myelin Disorders Biorepository Project

    open to all eligible people

    The Myelin Disorders Biorepository Project (MDBP) seeks to collect and analyze clinical data and biological samples from leukodystrophy patients worldwide to support ongoing and future research projects. The MDBP is one of the world's largest leukodystrophy biorepositories, having enrolled nearly 2,000 affected individuals since it was launched over a decade ago. Researchers working in the biorepository hope to use these materials to uncover new genetic etiologies for various leukodystrophies, develop biomarkers for use in future clinical trials, and better understand the natural history of these disorders. The knowledge gained from these efforts may help improve the diagnostic tools and treatment options available to patients in the future.

    San Francisco, California and other locations

Last updated: